Sign in

NCT07556861Not yet recruiting

Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform

Source: ClinicalTrials.gov · Last updated 31 Jul 2026

Brief summary (registry, in English)

The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving alcohol use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
22 Apr 2026
Start date
16 Sept 2026
Primary completion date
20 Jan 2029
Lead sponsor
Mayo Clinic
NCT number
NCT07556861

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 16 Sept 2026 to the primary completion date, 20 Jan 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Clinically unstable medical disease.

Other

  • Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment;
  • Needing a higher level of mental health care as demonstrated by ASAM\[36\] assessment; - completed by LADC or MD investigators
  • Already admitted into or about to initiate treatment in another addiction treatment program.
  • Currently attending High School. (can be 18 though)
  • Pregnancy confirmed by self-report
  • Inability to provide written informed consent.
  • Inability to understand English.
  • Otherwise excluded for administrative reasons and/or clinician judgment.

Who the study is looking for

  • Age\>=18 years;
  • History of bipolar I disorder, bipolar II disorder, or schizoaffective disorder of the bipolar type. Can be clinical diagnosis
  • Ability to read, write, and understand English;
  • Minimum DAST (1+) or AUDIT-C score (3+)
  • Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care;
  • Eligibility determined by ASAM Assessment as completed by a LADC.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Mayo Clinic in Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.